Cutler Group LP G1 Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	BUY	$2.1 - $4.83 $24,570 - $56,511	11,700 New	11,700 $1,000
Q1 2022 Apr 14, 2022	SELL	$7.6 - $11.02 $8,360 - $12,122	-1,100 Reduced 78.57%	300 $0
Q3 2021 Oct 26, 2021	SELL	$13.16 - $22.47 $11,844 - $20,223	-900 Reduced 39.13%	1,400 $0
Q2 2021 Jul 19, 2021	BUY	$19.57 - $26.32 $25,441 - $34,216	1,300 Added 130.0%	2,300 $2,000
Q4 2020 Jan 21, 2021	SELL	$10.99 - $20.4 $15,386 - $28,559	-1,400 Reduced 58.33%	1,000 $2,000
Q3 2020 Oct 27, 2020	BUY	$11.55 - $23.75 $11,550 - $23,750	1,000 Added 71.43%	2,400 $0
Q2 2020 Jul 22, 2020	SELL	$9.57 - $24.37 $6,699 - $17,059	-700 Reduced 33.33%	1,400 $1,000
Q1 2020 May 07, 2020	BUY	$9.07 - $26.32 $17,233 - $50,008	1,900 Added 950.0%	2,100 $1,000
Q4 2019 Feb 06, 2020	SELL	$20.54 - $31.0 $2,054 - $3,100	-100 Reduced 33.33%	200 $0
Q3 2019 Oct 28, 2019	BUY	$22.78 - $40.58 $6,834 - $12,174	300 New	300 $0

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.